Stockreport

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million [Yahoo! Finance]

Elutia, Inc. - Class A  (ELUT) 
PDF - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market - GAITHERSBURG, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq [Read more]